Paragon 28, Inc. is a medical device company focused on advancing the science of foot and ankle surgery. The company designs, develops, and distributes a comprehensive range of products including specialized plating systems, patient-specific implants, and biologics. Paragon 28 serves orthopedic surgeons and healthcare providers who specialize in foot and ankle procedures. Operating in the medical device market, the company leverages a business model that combines innovation with quality, ensuring that their products meet the highest standards of efficacy and safety. Revenue is generated through the sale of their proprietary surgical systems and implants, which are designed to improve patient outcomes and streamline surgical procedures. Key products include the Ankle Fracture Plating System, Hindfoot TTC TC System, and the Patient Specific Titanium Talus Spacer, which has received FDA approval. Paragon 28 is committed to research and development, continuously working to introduce new solutions that address the evolving needs of foot and ankle surgery.

Keywords: foot surgery, ankle surgery, orthopedic implants, plating systems, patient-specific implants, medical devices, FDA approved, surgical innovation, healthcare providers, orthopedic surgeons.